Khanh Ho, MD
Rheumatology · Baton Rouge, LANPI 1144253709
Payments from drug & device makers
Across 560 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Amgen$2K
- UCB, Inc.$816
- AstraZeneca$652
- GSK$526
- Novartis$521
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 157 | $3,562 |
| Amgen(2 entities) | 96 | $1,850 |
| UCB, Inc. | 31 | $816 |
| AstraZeneca(2 entities) | 28 | $652 |
| GSK | 41 | $526 |
| Novartis | 26 | $521 |
| Johnson & Johnson | 22 | $505 |
| Pfizer | 19 | $425 |
| Radius Health, Inc. | 18 | $420 |
| Aurinia Pharma U.S., Inc. | 19 | $399 |
| E.r. Squibb & Sons, L.L.C. | 19 | $354 |
| ANI Pharmaceuticals, Inc. | 12 | $299 |
| Boehringer Ingelheim | 13 | $250 |
| Fresenius Kabi USA, LLC | 8 | $178 |
| Sanofi | 7 | $175 |
| Genentech USA, Inc. | 10 | $167 |
| Lilly USA, LLC | 9 | $155 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
| Hikma Pharmaceuticals USA | 3 | $69 |
| Actelion Pharmaceuticals US, Inc. | 3 | $59 |
| Sobi, Inc | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| Organon | 4 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Medexus Pharma, Inc. | 2 | $23 |
| Pacira Therapeutics, Inc. | 1 | $20 |
How this compares
$11,745 in reported general payments places this provider in the 50th percentile of 88 rheumatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Baton Rouge
- Stephen LindseyBaton Rouge$3.6M
- Saravanan ThiagarajanBaton Rouge$1.2M
- Sean ShannonBaton Rouge$157K
- Randall BeylBaton Rouge$112K
- Chad HilleBaton Rouge$52K
- Ronald CerutiBaton Rouge$29K
- Joseph NesheiwatBaton Rouge$18K
- Jen ErbilBaton Rouge$17K
- Hector MenaBaton Rouge$15K
- Stephen PolletBaton Rouge$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.